Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) EBT Margin (2016 - 2025)

Historic EBT Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 8.0%.

  • Angiodynamics' EBT Margin rose 68900.0% to 8.0% in Q4 2025 from the same period last year, while for Nov 2025 it was 9.02%, marking a year-over-year increase of 738400.0%. This contributed to the annual value of 11.63% for FY2025, which is 514200.0% up from last year.
  • Angiodynamics' EBT Margin amounted to 8.0% in Q4 2025, which was up 68900.0% from 14.31% recorded in Q3 2025.
  • Angiodynamics' EBT Margin's 5-year high stood at 44.31% during Q3 2023, with a 5-year trough of 265.68% in Q1 2024.
  • Over the past 5 years, Angiodynamics' median EBT Margin value was 11.65% (recorded in 2021), while the average stood at 23.14%.
  • Per our database at Business Quant, Angiodynamics' EBT Margin crashed by -2537000bps in 2024 and then surged by 2595500bps in 2025.
  • Quarter analysis of 5 years shows Angiodynamics' EBT Margin stood at 11.32% in 2021, then grew by 6bps to 10.59% in 2022, then plummeted by -51bps to 15.96% in 2023, then increased by 7bps to 14.89% in 2024, then skyrocketed by 46bps to 8.0% in 2025.
  • Its last three reported values are 8.0% in Q4 2025, 14.31% for Q3 2025, and 7.62% during Q2 2025.